Delivery Order SPE2DB22D1106-SPE2DB24FFEX1

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,944.82 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of March 24, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,613.27 and a period of performance ending on February 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $1,948.03 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the medical product "MOUNJARO 10 MG/0.5 ML PEN 0.5ML" with a completion date of January 16, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,201.33, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a specialized pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a $7,342.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, which is a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025 and was awarded on March 26, 2025. It does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a $28,266.57 firm-fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract provides for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to...
This is a $1,632.54 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a period of performance through March 19, 2025 and was awarded on March 18, 2025. This delivery order contract is associated with a larger Indefinite Delivery Contract (IDC) valued...
This is a $9,115.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,733.60 firm fixed-price contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication. This delivery order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a $8,574.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DX15D1053|SPE2DX25F6DLU, is for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFEX1
    Delivery Order

This is a $1,052.00 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by August 1, 2024.

Generated 10/30/24, 9:56 AM